SEC 13F Intelligence

Decheng Capital Management III (Cayman), LLC / 430

Decheng Capital Management III (Cayman), LLC’s Terns Pharmaceuticals Inc Position

Does Decheng Capital Management III (Cayman), LLC own Terns Pharmaceuticals Inc (430)? Yes — 714.3K shares worth $4M (+1.20% of its 13F portfolio) as of Q4 2023.

Position Value
$4M
Q4 2023
Shares
714.3K
% of Portfolio
+1.20%
Quarters Held
8
currently held

Position History 430

Reported value by quarter
Q1 ’22: $2MQ1 ’22Q2 ’22: $2MQ2 ’22Q3 ’22: $4MQ3 ’22Q4 ’22: $7MQ4 ’22Q1 ’23: $8MQ1 ’23Q2 ’23: $6MQ2 ’23Q3 ’23: $4MQ3 ’23Q4 ’23: $4MQ4 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2023714.3K$4M+1.20%
Q3 2023714.3K$4M+1.15%
Q2 2023714.3K$6M+1.96%
Q1 2023714.3K$8M+3.41%
Q4 2022714.3K$7M+2.72%
Q3 2022714.3K$4M+1.53%
Q2 2022714.3K$2M+0.67%
Q1 2022714.3K$2M+0.65%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Decheng Capital Management III (Cayman), LLC’s full portfolio or all institutional holders of 430.